Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism

Anticancer Research

Volumn 20, Issue 6 B, 2000, Pages 4463-4471

  Riva, C M ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

galactosidase; Cationic liposomes; Cisplatin; Lung cancer cell lines; Primary pleural metastatic cells; Tumor suppressor gene

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PROTEIN P53; PROTEIN P53 SN3; UNCLASSIFIED DRUG; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; PLEURA TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; BETA-GALACTOSIDASE; CARCINOMA, BRONCHOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEASIBILITY STUDIES; GENES, P53; LAC OPERON; LIPOSOMES; LUCIFERASES; LUNG NEOPLASMS; NEOPLASM PROTEINS; PLEURAL EFFUSION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034484516     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. p53-immunoreactive cells in benign and maligant effusions: Diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining
2. Intrapleural cisplatin and cytarabin in the management of malignant pleural effusions: A lung cancer study group trial
3. A case report and description of the phamacokinetic behaviour of intrapleurally instilled etoposide
4. Long duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant pleural effusion
5. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
6. Normal p53 status and function despite the development of drug resistance in human breast cancer cells
7. Gene transfer in vivo with DNA-liposome complexes: Safety and acute toxicity in mice
8. Peripheral airway cell differentiation in human lung cancer cell lines
9. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines
10. A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies
11. Suppression of human colorectal carcinoma cell growth by wild-type p53
12. A rapid and sensitive method for quantitation of macrogram quantities of protein utilizing the principle of protein-dye binding
13. Chemosensitivity testing of human lung cancer cell lines using the MTT assay
14. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck
15. In situ apoptotic cell labeling by the TUNEL method: Improvement and evaluation on cell preparations
16. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions
17. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53
18. Mesothelial cell-mediated gene therapy: Feasability of an ex vivo strategy
19. Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus mediated gene transfer
20. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model
21. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis
22. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
23. The malignant pleural effusion: A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients
24. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents
25. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53
26. P53 immunolabeling in archival paraffin-embedded tissues: Optimal protocol based on microwave heating for eight antibodies on lung carcinomas
27. In vivo molecular therapy with p53 for microscopic residual head and neck squamous cell carcinoma
28. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells
29. Regression of established macroscopic liver metastases after in situ transduction of suicide gene
30. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma
31. Intrapleural cisplatin and citarabine in the management of malignat pleural effusions: A lung cancer study group trial
32. Induction of apoptosis in fibroblasts by c-myc protein
33. p53 status and the efficacy of cancer therapy in vivo
34. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of wild-type p53
35. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
36. Molecular thanaptosis: A discourse on the bcl-2 family and cell death
37. Antitumor activity of bax and p53 naked gene transfer in lung cancer: In vitro and in vivo analysis